Conference Presentations

Protagen actively participates in a number of scientific conferences across the world, where the company shares its latest research on autoimmune diseases and immuno-oncology, to help contribute to the development of more effective precision medicine approaches.

Protagen is passionate about collaborating with its partners and sharing its expertise at conferences. Here you can see a selection of Protagen’s most recent conference presentations and posters.

If you would like more information on any of the topics discussed, please contact us today.

American College of Rheumatology (ACR) annual meeting 2017

  • Differential Diagnosis of Autoimmune Diseases, Outlier Detection plus Subgrouping in Clinical Trials by High Content Autoantibody Profiling (PDF)
  • Autoantibody Profiling in Prostvac and Ipilimumab Treated Prostate Cancer Patients Reveals Potential Biomarkers of Immune-Related Adverse Events (PDF)
  • Development of a Multimarker Model for the Detection of Systemic Lupus Erythematosus Based on New and Traditional Autoantibodies (PDF)

 

 

Annual European Congress of Rheumatology (EULAR) 2017

  • Diagnostic Modeling of Systemic Lupus Erythematosus Based on New and Traditional Autoantibodies: Demonstration of Feasibility (PDF)
  • Multiparametric Detection of Autoantibodies to investigate Relationships between Serological and Clinical Subsets of Systemic Sclerosis Patients (PDF)
  • Serum autoantibody profiling of primary Sjögren’syndrome patients reveals novel biomarkers associated with the disease, disease activity, and clinical response to VAY736 (PDF)

 

 

American College of Rheumatology (ACR) annual meeting 2016

  • Discovery of Novel Autoantigens in Sjögren’s Syndrome with Potential for Subgrouping of Disease (PDF)
  • High-Throughput Screening Discovers Multiple Novel Autoantibodies in Rheumatoid Arthritis, Systemic Lupus, Systemic Sclerosis and Sjogren’s Disease (PDF)
  • Discovery and Subsequent Diagnostic Verification of Autoantibodies Against the Major Vault Protein (MVP) in Systemic Lupus Erythematosus (PDF)
  • Identifying and Assessing Subgroups in Systemic Sclerosis Patients based on Comprehensive Autoantibody Profiling (PDF)
  • The Novel Anti-BICD2 Autoantibody Potentially Predicts a Favorable Disease Course in Systemic Sclerosis (PDF)

 

European Lupus meeting 2016

  • Multiparametric detection of autoantibodies in Systemic Lupus Erythematosus (SLE) enables definition of SLE Patient Subgroups (PDF)
  • Discovery and initial validation of autoantibodies against the major vault protein (MVP) in systemic lupus erythematosus (PDF)

 

Biomarkers and Targeted Therapeutics in Sjögren’s 2016

  • Quantitative, Multiplex and Label-Free Detection of Sjögren’s Syndrome Autoantibodies on the Arrayed Imaging Reflectometry Platform (PDF)

 

Annual European Congress of Rheumatology (EULAR) 2016

  • High-Throughput Screening Discovers Novel Autoantibodies in Autoimmune Diseases: The SeroTag Approach in Systemic Lupus, Systemic Sclerosis and Rheumatoid Arthritis (PDF)
  • Validation of 3 Novel Biomarker Candidates for Systemic Sclerosis (PDF)
  • Confirmation of Serological Antibodies Against Novel Citrullinated Proteins in Early Rheumatoid Arthritis (PDF)

 

American College of Rheumatology (ACR) annual meeting 2015

  • Identification of homogeneous systemic lupus erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)
  • Validation of Novel Biomarker Candidates for Systemic Sclerosis (PDF)

 

12th Dresden Symposium on Autoantibodies 2015

  • Identification of homogeneous Systemic Lupus Erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)
  • Development of a qualitative ELISA for the detection of anti-BICD2 autoantibodies in Systemic Sclerosis (PDF)

 

Lupus 2015

  • Identification of homogeneous Systemic Lupus Erythematosus (SLE) patient groups using clustered autoantibody reactivities (PDF)

 

Annual European Congress of Rheumatology (EULAR) 2015

  • Identification of Novel Scleroderma–associated antigens and development of an autoantibody assay panel enabling their subsequent validation (PDF)
  • Discovery and validation of new autoantibody biomarker in Systemic Lupus Erythematosus (PDF)
  • Autoantibody profiling of late and early RA patients against citrullinated proteins (PDF)

 

American College of Rheumatology (ACR) annual meeting 2014

  • Development and validation of a diagnostic bead-based multiplex autoantibody assay (PDF)

 

Autoimmunity 2014

  • Development of a connective tissue disease array for differential diagnosis of ana-positive patients (PDF)
  • Validation of an autoantibody signature for the diagnosis of Rheumatoid Arthritis in an independent cohort (PDF)
  • Identification of subgroups of Systemic Lupus Erythematosus patients based on autoantibody profiling (PDF)

 

American College of Rheumatology (ACR) annual meeting 2013

  • Diagnostic autoantibody signatures of Rheumatoid Arthritis patients identified with a bead-based assay approach (PDF)
  • Identification of novel distinct autoantigen clusters reflecting the heterogeneity of Systemic Lupus Erythematosus (PDF)
  • Autoantibody profiles predict responsiveness to methotrexate and anti-tnf therapy in early Rheumatoid Arthritis (PDF)

 

European Committee for Treatment and Research in Multiple Sclerosis Congress 2013

  • Analysis of autoantibody signatures of Neuromyelitis Optica using protein arrays (PDF)

 

Scientific Publications

You can find out more about our technology applications and projects, and see in detail how these have been applied to successful diagnostic development projects.

Editorials

Protagen’s thought-leaders and experts regularly contribute technical and opinion articles to some of the industry’s most respected editorial publications, on the topics of autoimmune disease and immuno-oncology.

Data and Insight

As part of our mission to advance the treatment of cancer and autoimmune diseases, we have analyzed the immune responses of over 20,000 patients and healthy controls, leading to a unique, comprehensive, and permanently growing database.

Media and Resources

Here you will find a number of our visual resources that help explain some of the disease areas we work in, and the challenges we are overcoming. From animations to whitepapers and eBooks, see below for a number of downloadable resources.

Get in touch

Improving the treatment of cancer and autoimmune disease is our passion, and we always welcome the chance to discuss these topics with current and prospective customers, patients and clinicians alike.

We sometimes like to share the latest industry insights and company news, would you like to be added to our database?

9 + 11 =

Copyright © 1997-2018
Protagen AGDortmund, Germany